Sang-Cheol Bae Selected Research

Systemic Lupus Erythematosus (Libman-Sacks Disease)

5/2024	Remission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
4/2024	Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus.
2/2024	Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study.
12/2023	Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia.
12/2023	Association Between Severe Nonadherence to Hydroxychloroquine and Systemic Lupus Erythematosus Flares, Damage, and Mortality in 660 Patients From the SLICC Inception Cohort.
10/2023	Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study.
5/2023	SMART-SLE: serology monitoring and repeat testing in systemic lupus erythematosus - an analysis of anti-double-stranded DNA monitoring.
1/2023	Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes.
11/2022	Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
10/2022	Predictive Factors for Renal Response in Lupus Nephritis: A Single-center Prospective Cohort Study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sang-Cheol Bae Research Topics

Disease

126	Rheumatoid Arthritis 01/2024 - 08/2003
86	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2024 - 11/2002
14	Lupus Nephritis 10/2023 - 06/2007
14	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 01/2010
10	Infections 02/2022 - 04/2007
9	Inflammation (Inflammations) 10/2019 - 03/2006
9	Ankylosing Spondylitis 01/2018 - 08/2006
8	Rheumatic Diseases (Rheumatism) 07/2021 - 02/2010
7	Arthritis (Polyarthritis) 12/2023 - 09/2003
6	Proteinuria 12/2022 - 06/2013
6	Hypertension (High Blood Pressure) 10/2021 - 06/2013
6	Osteoarthritis 01/2018 - 09/2003
6	Tuberculosis (Tuberculoses) 01/2017 - 04/2007
5	Neoplasms (Cancer) 12/2021 - 05/2013
5	Pain (Aches) 04/2016 - 09/2003
4	Necrosis 01/2021 - 01/2013
4	Disease Susceptibility (Diathesis) 02/2018 - 11/2008
4	Genetic Predisposition to Disease (Genetic Predisposition) 08/2016 - 06/2008
3	Herpes Zoster 01/2023 - 01/2020
3	Osteonecrosis (Kienbock's Disease) 01/2022 - 11/2013
3	Osteoporosis 09/2016 - 07/2014
3	Vitamin D Deficiency 09/2016 - 12/2012
3	Nephritis 01/2016 - 04/2009
3	Psoriatic Arthritis 05/2014 - 01/2013
3	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 03/2013 - 05/2012
2	Serositis 12/2023 - 02/2004
2	Body Weight (Weight, Body) 10/2023 - 10/2019
2	Lung Diseases (Lung Disease) 01/2023 - 12/2012
2	Headache (Headaches) 12/2021 - 11/2013
2	Thrombosis (Thrombus) 07/2021 - 11/2013
2	Vasculitis (Vasculitides) 03/2019 - 03/2018

Drug/Important Bio-Agent (IBA)

23	Methotrexate (Mexate)FDA LinkGeneric 02/2022 - 05/2005
21	AutoantibodiesIBA 04/2024 - 01/2004
16	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 11/2004
15	Tumor Necrosis Factor InhibitorsIBA 01/2024 - 04/2007
11	AntibodiesIBA 04/2024 - 05/2007
10	GlucocorticoidsIBA 02/2024 - 01/2014
10	Etanercept (Enbrel)FDA Link 01/2017 - 04/2007
9	HLA-DRB1 Chains (HLA DRB1)IBA 01/2024 - 11/2004
8	DNA (Deoxyribonucleic Acid)IBA 05/2023 - 01/2004
7	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2012
7	Amino Acids FDA Link 01/2024 - 01/2012
7	Immunosuppressive Agents (Immunosuppressants)IBA 01/2023 - 05/2015
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021 - 06/2007
7	Antirheumatic Agents (DMARD)IBA 05/2018 - 09/2010
7	EpitopesIBA 06/2014 - 05/2007
6	belimumabIBA 12/2023 - 01/2016
6	Anti-Citrullinated Protein AntibodiesIBA 06/2014 - 05/2007
5	Adalimumab (Humira)FDA Link 02/2022 - 01/2013
5	Vitamin D FDA LinkGeneric 10/2021 - 12/2012
5	HLA Antigens (Human Leukocyte Antigens)IBA 07/2021 - 01/2014
5	Biosimilar PharmaceuticalsIBA 04/2019 - 01/2017
5	Infliximab (Remicade)FDA Link 05/2018 - 04/2007
5	Protein Tyrosine PhosphatasesIBA 04/2018 - 04/2012
5	cyclic citrullinated peptideIBA 06/2014 - 05/2007
4	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2023 - 05/2015
4	tofacitinibIBA 01/2023 - 09/2014
4	golimumab FDA Link 01/2022 - 06/2010
4	SteroidsIBA 01/2022 - 09/2010
4	Interferon Type IIBA 01/2022 - 01/2010
4	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021 - 11/2013
4	Antimalarials (Antimalarial Agents)IBA 12/2021 - 11/2013
4	hydroxide ionIBA 10/2021 - 08/2014
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2004
4	C-Reactive ProteinIBA 05/2019 - 08/2006
4	Rituximab (Mabthera)FDA Link 04/2019 - 11/2011
4	Interferon-gamma (Interferon, gamma)IBA 03/2015 - 11/2004
4	Peptides (Polypeptides)IBA 03/2015 - 01/2012
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2013 - 02/2010
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2008 - 01/2005
3	CytokinesIBA 03/2024 - 11/2004
3	Abatacept (Orencia)FDA Link 01/2024 - 11/2016
3	Tacrolimus (Prograf)FDA LinkGeneric 10/2023 - 02/2018
3	Antiphospholipid AntibodiesIBA 01/2023 - 01/2016
3	Antinuclear AntibodiesIBA 01/2022 - 08/2012
3	CreatinineIBA 10/2019 - 05/2013
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2019 - 01/2016
3	25-hydroxyvitamin DIBA 01/2018 - 08/2014
3	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2017 - 02/2009
3	ametantrone (HAQ)IBA 09/2016 - 01/2013
3	IgG Receptors (Fc gamma RI)IBA 06/2016 - 10/2014
3	HLA-B Antigens (HLA-B)IBA 11/2015 - 01/2012
3	Tuberculin (PPD)IBA 03/2015 - 02/2013
3	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 12/2014 - 07/2006
3	Interferon Regulatory FactorsIBA 02/2013 - 11/2008
3	Interleukin-10 (Interleukin 10)IBA 01/2013 - 11/2004
3	Interleukin-23 (Interleukin 23)IBA 12/2012 - 05/2009
3	glutathione S-transferase M1IBA 12/2012 - 05/2004
3	EnzymesIBA 01/2012 - 01/2005
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 09/2010 - 01/2005
3	AntioxidantsIBA 02/2009 - 11/2002
2	Prednisone (Sone)FDA LinkGeneric 12/2023 - 11/2022
2	Prednisolone (Predate)FDA LinkGeneric 10/2023 - 11/2021
2	GLPG0634IBA 02/2022 - 01/2021
2	HLA-G Antigens (HLA G)IBA 02/2021 - 06/2015
2	InterferonsIBA 01/2020 - 04/2012
2	Coffee FDA Link 10/2018 - 11/2014
2	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 10/2018 - 01/2016

Therapy/Procedure

35	Therapeutics 05/2024 - 02/2004
3	Tai Ji (Tai Chi Chuan) 03/2010 - 09/2003